IDEXX Laboratories revenue and financials

IDXX · NASDAQ · USD

$515.41Change from previous close: −2.21%Absolute change: −$11.66

Close · October 6, 2026

In the fiscal year ended December 2025, IDEXX Laboratories reported revenue of $4.3B (+10.42% year over year). Net income was $1.06B, a net margin of 24.6%.

Annual revenue · 2025: $4.3B
  1. $1.78B2016
  2. $1.97B2017
  3. $2.21B2018
  4. $2.41B2019
  5. $2.71B2020
  6. $3.22B2021
  7. $3.37B2022
  8. $3.66B2023
  9. $3.9B2024
  10. $4.3B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+10.42%
2025 vs 2024
Net income growth
+19.33%
2025 vs 2024
Net margin
24.6%
2024: 22.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item2025202420232022202120202019201820172016
Total assets3,3513,2933,2602,7472,4372,2951,8321,5371,7131,531
Current assets1,4141,4001,4951,1019561,063680654972846
Cash and equivalents18028845411314438490.3124188155
Receivables693561530491426—————
Inventory378382380368269—————
Net property, plant and equipment871829818768693—————
Goodwill414405366362359243240214200178
Other intangible assets11011284.597.799.0—————
Long-term investments31.831.030.330.35.3—————
Current liabilities1,1491,0689521,2367645837257701,005935
Accounts payable110114111110116—————
Long-term debt450618698770851909699602607594
Total debt9769871,0671,470——————
Total liabilities1,7451,6981,7752,1381,7471,6621,6551,5471,7671,639
Total equity (incl. minority)1,6051,5951,485609690—————
Retained earnings6,3925,3324,4453,6002,920—————
Minority interest———0.00.0—————